• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

FDA Approves Khindivi, First Oral Solution of Hydrocortisone, for Pediatric Patients

by MM360 Staff | May 29, 2025 | Myeloma News

Source: Pharmacy Times articles The formulation allows for individualized treatment in children with adrenocortical insufficiency. Read More

Publisher Correction: Predicting progression events in multiple myeloma from routine blood work

by MM360 Staff | May 29, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

FDA Approves Acoltremon Ophthalmic Solution 0.003% for Signs, Symptoms of Dry Eye Disease

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles Post Content Read More

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles This segment takes a deeper dive into toxicity management—focusing not just on what to monitor, but how institutions are putting these protocols into action in real-world clinical settings. Read More

Quadrivalent Meningococcal Vaccine Receives FDA Approval for Infants and Children With Meningococcal Disease

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles The FDA approved the MenQuadfi vaccine for young children, enhancing protection against invasive meningococcal disease and its severe complications. Read More

NLA 2025: Supporting Whole-Food Dietary Patterns vs Macronutrient Composition for Lipid Management

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles Alice H. Lichtenstein, DSc, emphasizes the importance of whole-food dietary patterns over macronutrient percentages for improving lipid profiles and cardiovascular health. Read More
« Older Entries
Next Entries »

Recent Content

  • Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis
  • Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses
  • Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
  • (no title)
  • The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review
  • (no title)
  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT